Feifan Zhang

Feifan Zhang is currently the Head of ALS Biostatistics at Amylyx Pharmaceuticals. Prior to this role, Feifan worked at GSK as a Clinical Statistician and at MetLife as a Data Scientist II. Feifan also has experience as a Biostatistician Intern at the Cardiovascular Research Foundation. Feifan obtained an MS in Biostatistics and a PhD in Biological Sciences from Columbia University.